Pennant Investors’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,100
Closed -$319K 20
2024
Q2
$319K Hold
13,100
0.08% 29
2024
Q1
$442K Hold
13,100
0.11% 23
2023
Q4
$413K Buy
+13,100
New +$413K 0.09% 24